<DOC>
	<DOCNO>NCT01673178</DOCNO>
	<brief_summary>This trial obese subject poor lipid control without Type 2 diabetes mellitus study safety , tolerability pharmacokinetics multiple dos PF-05231023</brief_summary>
	<brief_title>Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Male female subject nonchildbearing potential age 30 70 year without diagnosis Type 2 diabetes mellitus ( accord American Diabetes Association guideline ) . Subjects poor lipid control confirm laboratory test . BMI 30 40 Kg/m2 total body weight &gt; 50 kg ( 110 lb ) . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude asymptomatic , seasonal allergy time dose ) . Levels blood enzymes indicate pancreatitis elevate liver function enzyme outside laboratory 's reference range confirm laboratory test . Subjects Type 1 Diabetes Mellitus .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Type 2 diabetes</keyword>
	<keyword>safety</keyword>
	<keyword>multiple dose</keyword>
	<keyword>intravenous</keyword>
</DOC>